Inhibition of ERK1/2 activation in eccDNA-containing and ERK1/2 constitutively phosphorylated ovarian cancer cells markedly reduced eccDNA abundance and eccDNA-borne oncogene amplification and expression. The gene discussed is MAPK3; the disease is ovarian cancer.